ETFIQData as of Nov 18, 2026. · etfiq.com/funds/jdoc

JDOC Fact Sheet: JPMorgan Healthcare Leaders ETF

Share
$64.79
close, Nov 18, 2026

Over the year to Nov 18, 2026, JDOC returned +13.9% in total and charged 0.65% a year.

1-year total return
+13.9%
to Nov 18, 2026
Expense ratio
0.65%
a year
Net assets
$9.7m
on Nov 18, 2026
Net flow, last 3 trading days
$0
daily basis to Nov 16, 2026

Growth of $10,000, 1 year

JDOC $11,393 +13.9% · URTH $11,161 +11.6% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+4.4%
3 months+0.4%
Year to date+12.0%
1 year+13.9%
3 years+38.0%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
ELI LILLY AND COMPANY8.78%
ABBVIE INC COMMON STOCK8.47%
UNITEDHEALTH GROUP INC5.18%
JOHNSON & JOHNSON COMMON4.76%
NOVARTIS AG COMMON STOCK4.56%
THERMO FISHER SCIENTIFIC4.32%
ASTRAZENECA PLC COMMON4.11%
MERCK & CO INC COMMON3.49%
DANAHER CORP COMMON STOCK2.79%
INTUITIVE SURGICAL INC2.57%

JDOC top ten by weight, 49.0% of the fund, of its 53 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Actively managed · First traded Nov 2, 2023 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, JDOC Fact Sheet: JPMorgan Healthcare Leaders ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/jdoc/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/jdoc.